医学
恶性肿瘤
危险分层
放射科
医学诊断
医学物理学
病理
内科学
作者
Elizabeth A. Sadowski,Isabelle Thomassin‐Naggara,Andrea Rockall,Katherine E. Maturen,Rosemarie Forstner,Priyanka Jha,Stéphanie Nougaret,Evan S. Siegelman,Caroline Reinhold
出处
期刊:Radiology
[Radiological Society of North America]
日期:2022-01-18
卷期号:303 (1): 35-47
被引量:133
标识
DOI:10.1148/radiol.204371
摘要
MRI plays an important role as a secondary test or problem-solving modality in the evaluation of adnexal lesions depicted at US. MRI has increased specificity compared with US, decreasing the number of false-positive diagnoses for malignancy and thereby avoiding unnecessary or over-extensive surgery in patients with benign lesions or borderline tumors, while women with possible malignancies can be expeditiously referred for oncologic surgical evaluation. The Ovarian-Adnexal Reporting and Data System (O-RADS) MRI Committee is an international collaborative effort formed under the direction of the American College of Radiology and includes a diverse group of experts on adnexal imaging and management who developed the O-RADS MRI risk stratification system. This scoring system assigns a probability of malignancy based on the MRI features of an adnexal lesion and provides information to facilitate optimal patient management. The widespread implementation of a codified reporting system will lead to improved interpretation agreement and standardized communication between radiologists and referring physicians. In addition, it will allow for high-quality multi-institutional collaborations-an important unmet need that has hampered the performance of high-quality research in this area in the past. This article provides guidelines on using the O-RADS MRI risk stratification system in clinical practice, as well as in the educational and research settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI